Prebiotic galactooligosaccharides activate mucin and pectic galactan utilization pathways in the human gut symbiont Bacteroides thetaiotaomicron

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Van Bueren, Alicia Lammerts ^a   Mulder, Marieke ^a   Van Leeuwen, Sander ^a   Dijkhuizen, Lubbert ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN ENDO-1,4-BETA-GALACTOSIDASE; GALACTAN; GLYCOSIDASE; MUCIN; OLIGOSACCHARIDE; PECTIN; PREBIOTIC AGENT;

BACTEROIDES THETAIOTAOMICRON; DRUG EFFECT; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; SYMBIOSIS;

BACTEROIDES THETAIOTAOMICRON; GALACTANS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GLYCOSIDE HYDROLASES; HUMANS; MUCINS; OLIGOSACCHARIDES; PECTINS; PREBIOTICS; SYMBIOSIS;

EID: 85009895156     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40478     Document Type: Article

References (44)

1. Hooper, L. V. & Macpherson, A. J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10, 159-69 (2010).
2. Notghi, A., Hutchinson, R., Kumar, D., Smith, N. B. & Harding, L. K. Simplified method for the measurement of segmental colonic transit time. Gut 35, 976-981 (1994).
3. David, L. a. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-63 (2014).
4. Rogowski, A. et al. Glycan complexity dictates microbial resource allocation in the large intestine. Nat. Commun. 6, 7481, doi:10.1038/ncomms8481 (2015).
5. Martens, E. C. et al. Recognition and Degradation of Plant Cell Wall Polysaccharides by Two Human Gut Symbionts. Plos Biol. 9, e1001221 (2011).
6. Milani, C. et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci. Rep. 5, doi:10.1038/srep15782 (2015).
7. Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81, doi:10.3389/fgene.2015.00081 (2015).
8. Martens, E. C., Chiang, H. C. & Gordon, J. I. Mucosal Glycan Foraging Enhances Fitness and Transmission of a Saccharolytic Human Gut Bacterial Symbiont. Cell Host Microbe 4, 447-457 (2008).
9. Li, H. et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun, doi:10.1038/ncomms9292 (2015).
10. Corfield, A. P. Mucins: A biologically relevant glycan barrier in mucosal protection. Biochim. Biophys. Acta - Gen. Subj. 1850, 236-252 (2015).
11. Bergstrom, K. S. B. & Xia, L. Mucin-Type O-glycans and their roles in intestinal homeostasis. Glycobiology 23, 1026-1037 (2013).
12. Robbe, C., Capon, C., Coddeville, B. & Michalski, J.-C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 384, 307-16 (2004).
13. Sonnenburg, J. L. et al. Glycan foraging in vivo by an intestine-Adapted bacterial symbiont. Science 307, 1955-9 (2005).
14. Martens, E. C., Koropatkin, N. M., Smith, T. J. & Gordon, J. I. Complex glycan catabolism by the human gut microbiota: The Bacteroidetes Sus-like paradigm. J. Biol. Chem. 284, 24673-7 (2009).
15. Marcobal, A. et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10, 507-14 (2011).
16. Bode, L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22, 1147-62 (2012).
17. Bode, L. The functional biology of human milk oligosaccharides. Early Hum. Dev. 1-4, doi:10.1016/j.earlhumdev.2015.09.001 (2015).
18. Marcobal, a. & Sonnenburg, J. L. Human milk oligosaccharide consumption by intestinal microbiota. Clin. Microbiol. Infect. 18 Suppl 4, 12-5 (2012).
19. Newburg, D. S., Ruiz-Palacios, G. M. & Morrow, A. L. Human Milk Glycans Protect Infants Against Enteric Pathogens. Annu. Rev. Nutr. 25, 37-58 (2005).
20. Manthey, C. F., Autran, C. a., Eckmann, L. & Bode, L. Human Milk Oligosaccharides Protect Against Enteropathogenic Escherichia coli Attachment In Vitro and EPEC Colonization in Suckling Mice. J. Pediatr. Gastroenterol. Nutr. 58, 167-170 (2014).
21. Ben, X. et al. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin. Med. J. (Engl). 117, 927-931 (2004).
22. Davis, L. M. G., Martínez, I., Walter, J., Goin, C. & Hutkins, R. W. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 6, e25200 (2011).
23. Garrido, D. et al. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 33, 262-270 (2013).
24. Prenosil, J. E., Stuker, E. & Bourne, J. R. Formation of oligosaccharides during enzymatic lactose: Part I: State of art. Biotechnol. Bioeng. 30, 1019-1025 (1987).
25. van Leeuwen, S. S., Kuipers, B. J. H., Dijkhuizen, L. & Kamerling, J. P. Comparative structural characterization of 7 commercial galacto-oligosaccharide (GOS) products. Carbohydr. Res. 425, 48-58 (2016).
26. van Leeuwen, S. S., Kuipers, B. J. H., Dijkhuizen, L. & Kamerling, J. P. 1H NMR analysis of the lactose/β -galactosidase-derived galacto-oligosaccharide components of Vivinal® GOS up to DP5. Carbohydr. Res. 400, 59-73 (2014).
27. Park, A.-R. & Oh, D.-K. Galacto-oligosaccharide production using microbial β -galactosidase: current state and perspectives. Appl. Microbiol. Biotechnol. 85, 1279-1286 (2010).
28. Gietl, E. et al. Factors Involved in the In Vitro Fermentability of Short Carbohydrates in Static Faecal Batch Cultures. Int. J. Carbohydr. Chem. 2012, 1-10 (2012).
29. van Leeuwen, S. S., Kuipers, B. J. H., Dijkhuizen, L. & Kamerling, J. P. Development of a (1)H NMR structural-reporter-group concept for the analysis of prebiotic galacto-oligosaccharides of the [β -d-Galp-(1 → x)]n-d-Glcp type. Carbohydr. Res. 9-13, doi:10.1016/j.carres.2014.08.011(2014).
30. Lammerts van Bueren, A., Saraf, A., Martens, E. C. & Dijkhuizen, L. Differential Metabolism of Exopolysaccharides from Probiotic Lactobacilli by the Human Gut Symbiont Bacteroides thetaiotaomicron. Appl. Environ. Microbiol. 81, 3973-3983 (2015).
31. Cho, K. H., Cho, D., Wang, G. R. & Salyers, A. A. New regulatory gene that contributes to control of Bacteroides thetaiotaomicron starch utilization genes. J. Bacteriol. 183, 7198-7205 (2001).
32. Martens, E. C., Koropatkin, N. M., Smith, T. J. & Gordon, J. I. Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm. J. Biol. Chem. 284, 24673-24677 (2009).
33. Ryttersgaard, C. et al. The structure of endo-beta-1, 4-galactanase from Bacillus licheniformis in complex with two oligosaccharide products. J. Mol. Biol. 341, 107-17 (2004).
34. O'Connell Motherway, M., Kinsella, M., Fitzgerald, G. F. & van Sinderen, D. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb. Biotechnol. 6, 67-79 (2013).
35. Torpenholt, S. et al. Activity of three β - 1, 4-galactanases on small chromogenic substrates. Carbohydr. Res. 346, 2028-2033 (2011).
36. Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M. & Henrissat, B. The carbohydrate-Active enzymes database (CAZy) in 2013. Nucleic Acids Res. 42, D490-D495 (2014).
37. Sela, D. a. Bifidobacterial utilization of human milk oligosaccharides. Int. J. Food Microbiol. 149, 58-64 (2011).
38. Ruas-Madiedo, P., Gueimonde, M., Fernandez-Garcia, M., de los Reyes-Gavilan, C. G. & Margolles, a. Mucin Degradation by Bifidobacterium Strains Isolated from the Human Intestinal Microbiota. Appl. Environ. Microbiol. 74, 1936-1940 (2008).
39. Haarman, M. & Knol, J. Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebio. Appl. Environ. Microbiol. 71, 2318-2324 (2005).
40. Peacock, K. S., Ruhaak, L. R., Tsui, M. K., Mills, D. a. & Lebrilla, C. B. Isomer-specific consumption of galactooligosaccharides by bifidobacterial species. J. Agric. Food Chem. 61, 12612-9 (2013).
41. Wheatley, R. W., Lo, S., Jancewicz, L. J., Dugdale, M. L. & Huber, R. E. Structural Explanation for Allolactose (lac Operon Inducer) Synthesis by lacZ -Galactosidase and the Evolutionary Relationship between Allolactose Synthesis and the lac Repressor. J. Biol. Chem. 288, 12993-13005 (2013).
42. Koropatkin, N. M., Cameron, E. a. & Martens, E. C. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 10, 323-35 (2012).
43. Hungate, R. E. The Anaerobic Mesophilic Cellulolytic Bacteria. Microbiol. Mol. 14, 1-49 (1950).
44. Koropatkin, N. M. & Smith, T. J. SusG: A unique cell-membrane-Associated alpha-Amylase from a prominent human gut symbiont targets complex starch molecules. Structure 18, 200-215 (2010).